ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,473.17
-0.25%
Dow Jones
39,134.76
0.77%
US Dollar vs MXN
18.37515
-0.32%
Brent Oil
85.035
0.40%
Bitcoin
65,068.86
0.16%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Kintara Therapeutics Inc (KTRA)

  7. Kintara Therapeutics Inc (KTRA) Noticias

KTRA Kintara Therapeutics Inc

0.2751
0.0591 (27.36%)
Fuera de horario
Última actualización: 15:02:01
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Kintara Therapeutics Inc KTRA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.0591 27.36% 0.2751 15:02:01
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.2051 0.19 0.2997 0.2768 0.216
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
13/6/202415:10EDGAR2Form 425 - Prospectuses and communications, business..
13/6/202415:05EDGAR2Form 8-K - Current report
03/6/202407:50EDGAR2Form 425 - Prospectuses and communications, business..
03/6/202407:45EDGAR2Form 8-K - Current report
03/6/202407:35PRNUSTuHURA Biosciences and Kintara Therapeutics Announce..
17/5/202415:10EDGAR2Form ARS - Annual Report to Security Holders
17/5/202415:05EDGAR2Form DEF 14A - Other definitive proxy statements
14/5/202415:55EDGAR2Form 425 - Prospectuses and communications, business..
14/5/202415:50EDGAR2Form 8-K - Current report
14/5/202415:45PRNUSKintara Therapeutics Announces Fiscal 2024 Third Quarter..
14/5/202415:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202415:06EDGAR2Form S-4 - Registration of securities, business combinations
05/4/202412:09PRNUSKuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to..
03/4/202406:00PRNUSKintara Therapeutics and TuHURA Biosciences Enter into..
27/3/202408:00PRNUSKintara Therapeutics Announces Expansion of REM-001 Clinical..
27/2/202405:59EDGAR2Form 8-K - Current report
26/2/202406:00EDGAR2Form 8-K - Current report
22/2/202406:00EDGAR2Form 8-K - Current report
14/2/202415:07PRNUSKintara Therapeutics Announces Fiscal 2024 Second Quarter..
12/2/202408:05EDGAR2Form 8-K - Current report
12/2/202408:00PRNUSKintara Therapeutics Announces Initiation of REM-001..
18/12/202315:10EDGAR2Form 8-K - Current report
18/12/202315:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/12/202315:15EDGAR2Form 8-K - Current report
07/12/202308:10EDGAR2Form 8-K - Current report
07/12/202308:00PRNUSKintara Therapeutics Announces Review of Strategic..
05/12/202308:10EDGAR2Form 8-K - Current report
05/12/202308:00PRNUSKintara Therapeutics Granted Extension by Nasdaq to Regain..
21/11/202306:55EDGAR2Form 8-K - Current report
13/11/202315:15EDGAR2Form 8-K - Current report
13/11/202315:10PRNUSKintara Therapeutics Announces Fiscal 2024 First Quarter..
13/11/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202307:10EDGAR2Form 8-K - Current report
31/10/202307:00PRNUSKintara Therapeutics Announces Preliminary Topline Results..
27/10/202315:05EDGAR2Form S-1/A - General form for registration of securities..
24/10/202315:43EDGAR2Form S-1/A - General form for registration of securities..
10/10/202315:06EDGAR2Form 8-K - Current report
04/10/202315:35EDGAR2Form S-1 - General form for registration of securities under..
26/9/202315:09EDGAR2Form 8-K - Current report
21/9/202308:35GLOBEDawson James Securities Announces October Date for 8th..
19/9/202315:20EDGAR2Form 8-K - Current report
19/9/202315:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/9/202315:31EDGAR2Form 8-K - Current report
18/9/202315:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/9/202315:06EDGAR2Form DEF 14A - Other definitive proxy statements
01/9/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202315:05EDGAR2Form PRE 14A - Other preliminary proxy statements
30/6/202316:11EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
KTRA
Kintara Therapeutics
COIN
SOPHUSD
SOPH AI Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados